Authors


Ron Chiarello, Ph.D.

Latest:

When Molecular Testing is Superior to Antigen Testing for Infectious Diseases

Providing people with the ability to test for viruses in their own homes empowers them to be proactive about their health while helping public health officials, policymakers, and researchers with information that could head off the next pandemic.


Melek Hursid, PharmD, MBA

Latest:

Quizartinib Approved for Newly Diagnosed AML in Patients with ITD

Overall median survival was higher in participants taking quizartinib, according to results from QuANTUM-First trial.


Don Via, a Good Neighbor Pharmacy Business Coach at AmerisourceBergen

Latest:

Three Small Staffing Changes That Can Boost Your Pharmacy's Profits

Although there's no magic formula for finding the appropriate pharmacy staffing levels, there are subtle shifts you can make that will have a big impact on your bottom line.


Gabriella Salerno, PharmD

Latest:

FDA Approves Voquezna for Helicobacter pylori Infection in Adults

This new treatment option copackages 3 drugs for optimal treatment.


James Thurston, PharmD Candidate

Latest:

TICOVAC Vaccine to Prevent Tick-Borne Encephalitis

The FDA approved a biologics license application for the tick-borne encephalitis (TBE) vaccine TICOVAC for individuals 1 year or older.


Judy Neville, CPhT

Latest:

Pharmacy Technicians on the Front Line of Health Care

The need for skilled and knowledgeable pharmacy technicians in our workforce remains steady throughout current times.


Rachel Pearlman, PharmD candidate

Latest:

The Evolution of Pharmacogenomics

Pharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.


Teri Metcalf McCambridge, MD

Latest:

OTC Medications to Treat the Young Athlete

A variety of nonprescription treatments, supplements, and patches can alleviate pain for children and adolescents.


Jeffrey Benedix

Latest:

Patient Treatment Costs to rise 7% in 2024, Report Finds

The increase is expected to be somewhat offset by the impact of biosimilars coming to market and more care being provided in outpatient settings.


Innocent Clement, M.D., M.P.H., MBA

Latest:

How Can Improving Provider-Patient Relationships Help Reverse Chronic Disease?

The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.


Mary Caffrey

Latest:

Nobel Prize Awarded to Scientists Whose mRNA Work Allowed Development of COVID-19 Vaccines

Katalin Karikó, PhD, and Drew Weissman, MD, PhD, were cited "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."


Feryal Alhamadani, PharmD

Latest:

Elranatamab-bcmm Approved for Adult Patients With Relapsed or Refractory Multiple Myeloma

The novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.


Gina Mauro

Latest:

Pembrolizumab Approved in China for Frontline Advanced Esophageal Cancer

The National Medical Products Administration in China has approved pembrolizumab for use in combination with platinum and fluoropyrimidine-based chemotherapy for the frontline treatment of patients.


Pearl Steinzor

Latest:

Study: Biologic Therapies Improve Clinical Outcomes in Patients With Severe Asthma

Improvement across all asthma control parameters was achieved after 12 months of biologic treatment with mepolizumab, benralizumab, and omalizumab.


Gianna Melillo

Latest:

The Role of Complementary and Alternative Medicine in Pharmacy

It’s crucial to be openminded about these approaches, and to convey accurate information to patients in a nonjudgmental manner.


Anne Chau

Latest:

Data, Collaboration Can Help Unlock the Full Potential of Value-Based Care

A unified data ecosystem will provide the foundation for the next generation of patient-care technology.


Brock Ingmire

Latest:

How to Help Make Health Equity a Reality

CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.


Jennifer Gershman, PharmD, CPh, PACS

Latest:

Two-Dose HepB Vaccine Not Associated With Increased Risk of Acute MI

The 2-dose hepatitis B vaccine was not associated with a higher risk of acute myocardial infarction compared with the 3-dose hepatitis B vaccine series.


Kaitlyn Bader

Latest:

Roflumilast Foam 0.3% Secures Major FDA Approval to Treat Seborrheic Dermatitis

The foam formulation and once-daily application of roflumilast foam 0.3%, the first FDA-approved drug for seborrheic dermatitis with a new mechanism of action in over 2 decades, makes it a favorable alternative to existing treatments.


John Kassis, PharmD

Latest:

Barhemsys (Amisulpride) for Postoperative Nausea and Vomiting

On February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.


Tim Smith

Latest:

COPD Exacerbations Reduced Substantially With Dupilumab, Phase 3 Data Shows

The NOTUS trial was shown to have successfully achieved its primary endpoint, demonstrating the notable efficacy of dupilumab in reducing exacerbations by 34% versus placebo in individuals with moderate-to-severe COPD showing evidence of type 2 inflammation.


Rachel Lutz

Latest:

A Surge in Mpox Cases Could Occur This Summer

Demetre Daskalakis, MD, MPH, urged those in the LGBTQ+ community to get fully vaccinated against the disease.


Jared Kaltwasser

Latest:

Commercial Plan Members Aren't Embracing Digital Health Tools

A survey found that patients satisfaction with the technology declined modestly in 2023, down 13 points on a 1,000-point scale.



Diana Issacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

Latest:

Continuous Glucose Monitoring and Its Part in Diabetes Management

Continuous glucose monitoring has many benefits and can improve disease management in for both diabetes types.


Janet Walker

Latest:

How to Help Make Health Equity a Reality

CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.


Joshua Fitch

Latest:

Repeat Dosing Study Demonstrates Positive Data for Neffy Epinephrine Nasal Spray

Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.



Chris Cella

Latest:

Understanding the Foundations of Pharmacy Financial Health

Pharmacy schools specialize in training students as experts in patient care—not as expert business owners.


Sandra Bond Chapman, PhD

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important

© 2024 MJH Life Sciences

All rights reserved.